Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

CONMED ($CNMD) Releases Q1 2026 Earnings

None

CONMED ($CNMD) posted quarterly earnings results for Q1 2026 on Wednesday, April 29th. The company reported earnings of $0.89 per share, beating estimates of $0.84 by $0.05. The company also reported revenue of $317,050,000, beating estimates of $316,716,803 by $333,197.

You can see Quiver Quantitative's $CNMD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CONMED Insider Trading Activity

CNMD Insider Trades

CONMED insiders have traded $CNMD stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CNMD stock by insiders over the last 6 months:

  • TODD W GARNER (Executive Vice President & CFO) sold 3,500 shares for an estimated $150,500
  • RICHARD GLAZE (Chief Information Officer) sold 257 shares for an estimated $10,590

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

CONMED Hedge Fund Activity

We have seen 132 institutional investors add shares of CONMED stock to their portfolio, and 153 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

CONMED Government Contracts

We have seen $127,879 of award payments to $CNMD over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

CONMED Price Targets

Multiple analysts have issued price targets for $CNMD recently. We have seen 4 analysts offer price targets for $CNMD in the last 6 months, with a median target of $47.0.

Here are some recent targets:

  • Matt O'Brien from Piper Sandler set a target price of $39.0 on 03/17/2026
  • Vik Chopra from Wells Fargo set a target price of $42.0 on 01/29/2026
  • Travis Steed from B of A Securities set a target price of $52.0 on 12/08/2025
  • Robbie Marcus from JP Morgan set a target price of $52.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles